成人2型糖尿病的管理：聚焦非胰岛素治疗的个体化
Management of type-2 diabetes mellitus in adults: focus on individualizing non-insulin therapies.
作者信息
Brunetti Luigi, Kalabalik Julie
出版信息
P T. 2012 Dec;37(12):687-96.
Abstract
Successful management of hyperglycemia may involve glucose and non-glucose therapies, non-drug approaches, and non-insulin agents. Treatment should be tailored to each patient, with an emphasis on safety.
摘要
高血糖的成功管理可能涉及葡萄糖和非葡萄糖疗法、非药物方法以及非胰岛素药物。治疗应根据每位患者的情况进行调整，重点是安全性。
相似文献
1
2
Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance.1型糖尿病青少年和成人中基于比例积分微分系统的自动混合闭环控制：个性化设置以实现最佳性能。
Pediatr Diabetes. 2017 Aug;18(5):348-355. doi: 10.1111/pedi.12399. Epub 2016 May 18.
3
Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies.2型糖尿病的药物治疗：现有疗法
Am J Med. 2017 Jun;130(6S):S4-S17. doi: 10.1016/j.amjmed.2017.04.004.
4
Pharmacotherapies for diabetes management: an update for the practicing clinician.糖尿病管理的药物治疗：给临床执业医师的最新资讯
Semin Thorac Cardiovasc Surg. 2006 Winter;18(4):379-89. doi: 10.1053/j.semtcvs.2007.01.003.
5
A patient-centered approach to managing patients with type 2 diabetes.以患者为中心的方法管理 2 型糖尿病患者。
Am J Med. 2014 Nov;127(11):e15-e16. doi: 10.1016/j.amjmed.2014.10.007. Epub 2014 Oct 15.
6
Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies.2型糖尿病的药物治疗：现有疗法
Am J Cardiol. 2017 Jul 1;120(1S):S4-S16. doi: 10.1016/j.amjcard.2017.05.009. Epub 2017 May 30.
7
Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.心理干预对改善 1 型和 2 型糖尿病自我管理的效果：系统综述。
Health Technol Assess. 2020 Jun;24(28):1-232. doi: 10.3310/hta24280.
8
Randomized clinical trial of the efficacy and safety of insulin glargine vs. NPH insulin as basal insulin for the treatment of glucocorticoid induced hyperglycemia using continuous glucose monitoring in hospitalized patients with type 2 diabetes and respiratory disease.在2型糖尿病合并呼吸系统疾病的住院患者中，使用连续血糖监测比较甘精胰岛素与中性鱼精蛋白锌胰岛素作为基础胰岛素治疗糖皮质激素诱导的高血糖的疗效和安全性的随机临床试验。
Diabetes Res Clin Pract. 2015 Nov;110(2):158-65. doi: 10.1016/j.diabres.2015.09.015. Epub 2015 Sep 30.
9
Glucose regulation in non-insulin-dependent diabetes mellitus. Interaction between pancreatic islets and the liver.非胰岛素依赖型糖尿病中的葡萄糖调节。胰岛与肝脏之间的相互作用。
Am J Med. 1985 Aug 23;79(2B):6-12. doi: 10.1016/0002-9343(85)90579-0.
10
Practical considerations for the use of sodium-glucose co-transporter type 2 inhibitors in treating hyperglycemia in type 2 diabetes.2型糖尿病中使用钠-葡萄糖协同转运蛋白2抑制剂治疗高血糖的实际考量
Curr Med Res Opin. 2016 Jun;32(6):1097-108. doi: 10.1185/03007995.2016.1161608. Epub 2016 Apr 4.
引用本文的文献
1
Dietary Polyphenols as Potential Therapeutic Agents in Type 2 Diabetes Management: Advances and Opportunities.膳食多酚作为2型糖尿病管理中的潜在治疗剂：进展与机遇
Adv Nutr. 2025 Jan;16(1):100346. doi: 10.1016/j.advnut.2024.100346. Epub 2024 Nov 19.
2
Prevalence and predictors of type 2 diabetes complications: a single centre observation.2 型糖尿病并发症的患病率及其预测因素：一项单中心观察研究。
Afr Health Sci. 2023 Sep;23(3):308-317. doi: 10.4314/ahs.v23i3.37.
3
Changes in Cardiovascular and Renal Biomarkers Associated with SGLT2 Inhibitors Treatment in Patients with Type 2 Diabetes Mellitus.2型糖尿病患者中与SGLT2抑制剂治疗相关的心血管和肾脏生物标志物变化
Pharmaceutics. 2023 Oct 25;15(11):2526. doi: 10.3390/pharmaceutics15112526.
4
A Randomized, Double-Blind, Parallel-Group Phase III Trial Investigating the Glycemic Efficacy and Safety Profile of Fixed-Dose Combination Dapagliflozin and Linagliptin Over Linagliptin Monotherapy in Patients with Inadequately Controlled Type 2 Diabetes with Metformin.一项随机、双盲、平行组III期试验，研究固定剂量组合达格列净和利格列汀对比利格列汀单药治疗对二甲双胍控制不佳的2型糖尿病患者的血糖疗效和安全性。
Diabetes Ther. 2024 Jan;15(1):215-227. doi: 10.1007/s13300-023-01504-3. Epub 2023 Nov 14.
5
Inhibitory Efficacy of Cycloartenyl Ferulate against α-Glucosidase and α-Amylase and Its Increased Concentration in Gamma-Irradiated Rice (Germinated Rice).环阿屯醇阿魏酸酯对α-葡萄糖苷酶和α-淀粉酶的抑制作用及其在γ辐照大米（发芽大米）中含量的增加
Prev Nutr Food Sci. 2023 Jun 30;28(2):170-177. doi: 10.3746/pnf.2023.28.2.170.
6
An Update on the Molecular and Cellular Basis of Pharmacotherapy in Type 2 Diabetes Mellitus.2 型糖尿病药物治疗的分子和细胞基础的最新进展。
Int J Mol Sci. 2023 May 26;24(11):9328. doi: 10.3390/ijms24119328.
7
Drug therapy and medication adherence in type 2 diabetes in a care facility: A cross sectional survey.护理机构中2型糖尿病的药物治疗与用药依从性：一项横断面调查。
Explor Res Clin Soc Pharm. 2022 Nov 4;8:100200. doi: 10.1016/j.rcsop.2022.100200. eCollection 2022 Dec.
8
Natural α-Glucosidase and Protein Tyrosine Phosphatase 1B Inhibitors: A Source of Scaffold Molecules for Synthesis of New Multitarget Antidiabetic Drugs.天然α-葡萄糖苷酶和蛋白酪氨酸磷酸酶 1B 抑制剂：用于合成新型多靶标抗糖尿病药物的支架分子的来源。
Molecules. 2021 Aug 9;26(16):4818. doi: 10.3390/molecules26164818.
9
Susceptibility for Some Infectious Diseases in Patients With Diabetes: The Key Role of Glycemia.糖尿病患者某些传染病易感性：血糖的关键作用。
Front Public Health. 2021 Feb 16;9:559595. doi: 10.3389/fpubh.2021.559595. eCollection 2021.
10
Impact of DPP4 Inhibitors in Survival of Patients With Prostate, Pancreas, and Breast Cancer.二肽基肽酶4抑制剂对前列腺癌、胰腺癌和乳腺癌患者生存率的影响
Front Oncol. 2020 Mar 31;10:405. doi: 10.3389/fonc.2020.00405. eCollection 2020.
本文引用的文献
1
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).2型糖尿病高血糖管理：以患者为中心的方法：美国糖尿病协会（ADA）和欧洲糖尿病研究协会（EASD）的立场声明
Diabetes Care. 2012 Jun;35(6):1364-79. doi: 10.2337/dc12-0413. Epub 2012 Apr 19.
2
Clinical practice. Glycemic management of type 2 diabetes mellitus.临床实践。2型糖尿病的血糖管理。
N Engl J Med. 2012 Apr 5;366(14):1319-27. doi: 10.1056/NEJMcp1013127.
3
Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.二肽基肽酶-4 抑制剂在临床环境中治疗 2 型糖尿病的系统评价和荟萃分析。
BMJ. 2012 Mar 12;344:e1369. doi: 10.1136/bmj.e1369.
4
American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults.美国老年医学学会更新了老年人潜在不适当药物使用的 Beers 标准。
J Am Geriatr Soc. 2012 Apr;60(4):616-31. doi: 10.1111/j.1532-5415.2012.03923.x. Epub 2012 Feb 29.
5
Standards of medical care in diabetes--2012.《糖尿病医疗护理标准——2012》
Diabetes Care. 2012 Jan;35 Suppl 1(Suppl 1):S11-63. doi: 10.2337/dc12-s011.
6
2010 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th Annual Report.2010 年美国毒物控制中心协会国家毒物数据系统（NPDS）年度报告：第 28 次年度报告。
Clin Toxicol (Phila). 2011 Dec;49(10):910-41. doi: 10.3109/15563650.2011.635149.
7
Emergency hospitalizations for adverse drug events in older Americans.老年人因药物不良反应而紧急住院的情况。
N Engl J Med. 2011 Nov 24;365(21):2002-12. doi: 10.1056/NEJMsa1103053.
8
Lower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives: results from a large population-based follow-up study.与使用磺酰脲类衍生物的患者相比，使用二甲双胍的患者癌症风险更低：一项大型基于人群的随访研究结果。
Diabetes Care. 2012 Jan;35(1):119-24. doi: 10.2337/dc11-0857. Epub 2011 Nov 18.
9
Saxagliptin and sitagliptin in adult patients with type 2 diabetes: a systematic review and meta-analysis.沙格列汀和西格列汀在 2 型糖尿病成年患者中的应用：系统评价和荟萃分析。
Diabetes Obes Metab. 2012 Jun;14(6):481-92. doi: 10.1111/j.1463-1326.2011.01540.x. Epub 2011 Dec 27.
10
Pioglitazone and bladder cancer.吡格列酮与膀胱癌
Lancet. 2011 Oct 29;378(9802):1544; author reply 1544-5. doi: 10.1016/S0140-6736(11)61663-2.
Zotero 插件